P, T., J, M., H, H., K, M., & JS, A. (2023). Stimulant Medication Treatment in Children with Congenital Heart Disease and Attention-Deficit/Hyperactivity Disorder: Cardiovascular Outcomes. Journal of developmental and behavioral pediatrics : JDBP, 44(4), e247. https://doi.org/10.1097/DBP.0000000000001187
Chicago Style (17th ed.) CitationP, Trairatvorakul, Meinzen-Derr J, Heydarian H, Mason K, and Anixt JS. "Stimulant Medication Treatment in Children with Congenital Heart Disease and Attention-Deficit/Hyperactivity Disorder: Cardiovascular Outcomes." Journal of Developmental and Behavioral Pediatrics : JDBP 44, no. 4 (2023): e247. https://doi.org/10.1097/DBP.0000000000001187.
MLA (9th ed.) CitationP, Trairatvorakul, et al. "Stimulant Medication Treatment in Children with Congenital Heart Disease and Attention-Deficit/Hyperactivity Disorder: Cardiovascular Outcomes." Journal of Developmental and Behavioral Pediatrics : JDBP, vol. 44, no. 4, 2023, p. e247, https://doi.org/10.1097/DBP.0000000000001187.